Purchase Order HHSN2682006MJ613005P

<p>This is a definitive contract awarded by the National Cancer Institute, a civilian agency, to the National Public Health Institute in Finland. The contract is for the follow-up of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) study cohort, with a ceiling value of $11,647,439.31 and a completion date of November 30, 2009. The contract was awarded on March 15, 2003 and does not have a set-aside designation.</p>

This contract was awarded by the Department of Health and Human Services Agency for Healthcare Research and Quality (AHRQ) to the Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration, to provide research on therapies for clinically localized prostate cancer. The contract is a delivery order under the AHRQ's Evidence-based Practice Centers (EPC V) indefinite delivery contract, with a firm fixed price of $355,000.00 and a completion date of...

This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to the Connecticut Department of Public Health's Business Office Division. The contract is for a &quot;Patterns of Care/Quality of Care Study: Diagnosis Year 2014 (SEER)&quot; with a potential value of $49,084.00 and a completion date of August 14, 2016. The contract supports the Surveillance, Epidemiology, and End Results (SEER)...

This is a $138,343.00 firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Emory University, a private research university in Atlanta, Georgia. The contract is part of the Surveillance Epidemiology and End Results (SEER) Patterns of Care (POC)/Quality of Care Study for diagnosis year 2019, focusing on urinary bladder cancer and kidney cancer. Emory University, through its Office of Sponsored Programs Division, is the prime contractor for this study. The...

This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to the Public Health Institute (PHI), a non-profit organization. The contract, valued at $149,693.00, was for a &quot;Patterns of Care/Quality of Care Study-Diagnosis Year 2012&quot; under the Surveillance, Epidemiology, and End Results (SEER) program. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type and has no set-aside designation....

The Centers for Disease Control and Prevention (CDC) awarded a $377,278 firm fixed price contract to Fred Hutchinson Cancer Center, doing business as Seattle Cancer Care Alliance (SCCA), to conduct consultation and cancer research services. SCCA will perform comparative modeling through its Cancer Intervention and Surveillance Modeling Network (CISNET) prostate cancer working group to analyze potential outcomes if Gleason score 6 prostate cancer were reclassified as a non-cancer diagnosis. The...

This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) to Westat, Inc., a for-profit provider of professional services to government agencies. The $199,488.00 firm fixed-price contract is a call under the Achieving Public Health Impact Through Research (APHITR) blanket purchase agreement (BPA). The contract supports the APHIR PROSTATE CANCER program, with work to be performed in Potomac, Maryland. Westat has a track record of...

The U.S. Agency for Healthcare Research and Quality (AHRQ) awarded a $417,000.00 firm-fixed-price delivery order contract to the Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration, to provide services for the treatment of stage I-III squamous cell carcinoma (SCC) of the anal canal. This contract does not have a set-aside designation. The University of Minnesota is a major research institution that frequently partners with federal agencies to...

This federal contract award was issued by the National Cancer Institute, a component of the U.S. Department of Health and Human Services, to the Connecticut Department of Public Health. The $47,682.81 delivery order is for a &quot;Patterns of Care/Quality of Care Study: Diagnosis Year 2013&quot; as part of the Surveillance, Epidemiology, and End Results (SEER) Program, a major cancer surveillance initiative. The contract is a cost-no-fee arrangement without any set-aside designation. The...

Emory University was awarded a $249,215.40 firm fixed price purchase order by the National Cancer Institute, part of the Department of Health and Human Services, to conduct a study investigating exposure to perfluorooctanoic acid (PFOA) and mutational signatures in clear cell renal cell carcinoma. The study will involve analyzing plasma samples from 1,330 subjects, including 1,085 renal cancer cases and 245 healthy controls, to assess the association between PFOA and other per- and...